Dataset from A Randomized, Double-blind, Placebo Controlled, Two Period Crossover Study to Investigate the Pharmacokinetics, Tolerability and Cognitive Effects of an Oral Dose Regimen of 150mg Tid CNV1014802 in Healthy Young Versus Elderly Male and Female Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009291
下载链接
链接失效反馈官方服务：
资源简介：
A randomized, double-blind, placebo controlled, two period crossover study to investigate the
pharmacokinetics, tolerability and cognitive effects of 8 days dosing of CNV1014802 in
healthy young versus elderly male and female subjects. Treatment periods will be separated by
13 days. The primary outcome measures are pharmacokinetics (PK) and tolerability.
创建时间：
2025-07-07
